论文部分内容阅读
作者从 1995～ 2 0 0 2年分别开展了基因重组链激酶 (rSK)、天普洛欣尿激酶 (TPUK)和重组组织型纤溶酶原激活剂 (rtpA) ,静脉溶栓治疗急性脑梗死的研究 ,现就其临床疗效方面进行对比分析 ,仅供同道参考。1 资料与方法1.1 一般资料 急性脑梗死患者 180例 ,男 10 6例 ,女 74例
The authors carried out gene recombinant streptokinase (rSK), diphtheriae urokinase (TPUK) and recombinant tissue plasminogen activator (rtpA) from 1995 to 2002, intravenous thrombolysis in patients with acute cerebral infarction Of the study, is the comparative analysis of its clinical efficacy, for fellow reference only. 1 Materials and Methods 1.1 General Information 180 patients with acute cerebral infarction, 106 males and 74 females